Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

A comparative chemical-biological evaluation of titanium(IV) complexes with a salan or cyclopentadienyl ligand.

Schur J, Manna CM, Deally A, Köster RW, Tacke M, Tshuva EY, Ott I.

Chem Commun (Camb). 2013 May 25;49(42):4785-7. doi: 10.1039/c3cc38604j.

PMID:
23598498
2.

A marked synergistic effect in antitumor activity of salan titanium(IV) complexes bearing two differently substituted aromatic rings.

Glasner H, Tshuva EY.

J Am Chem Soc. 2011 Oct 26;133(42):16812-4. doi: 10.1021/ja208219f. Epub 2011 Oct 4.

PMID:
21967133
3.

Heteroleptic titanium(IV) catecholato/piperazine systems and their anti-cancer properties.

Hancock SL, Gati R, Mahon MF, Tshuva EY, Jones MD.

Dalton Trans. 2014 Jan 21;43(3):1380-5. doi: 10.1039/c3dt52583j. Epub 2013 Nov 7.

PMID:
24201896
4.

Cytotoxic dinuclear titanium-salan complexes: structural and biological characterization.

Immel TA, Grützke M, Batroff E, Groth U, Huhn T.

J Inorg Biochem. 2012 Jan;106(1):68-75. doi: 10.1016/j.jinorgbio.2011.08.029. Epub 2011 Sep 14.

PMID:
22112842
5.

Cytotoxic salan-titanium(IV) complexes: high activity toward a range of sensitive and drug-resistant cell lines, and mechanistic insights.

Manna CM, Braitbard O, Weiss E, Hochman J, Tshuva EY.

ChemMedChem. 2012 Apr;7(4):703-8. doi: 10.1002/cmdc.201100593. Epub 2012 Jan 20.

PMID:
22262543
6.

High antitumor activity of highly resistant salan-titanium(IV) complexes in nanoparticles: an identified active species.

Meker S, Margulis-Goshen K, Weiss E, Magdassi S, Tshuva EY.

Angew Chem Int Ed Engl. 2012 Oct 15;51(42):10515-7. doi: 10.1002/anie.201205973. Epub 2012 Sep 7.

PMID:
22961758
7.

First polymer "ruthenium-cyclopentadienyl" complex as potential anticancer agent.

Valente A, Garcia MH, Marques F, Miao Y, Rousseau C, Zinck P.

J Inorg Biochem. 2013 Oct;127:79-81. doi: 10.1016/j.jinorgbio.2013.07.002. Epub 2013 Jul 12.

PMID:
23896008
8.

Cytotoxic titanium salan complexes: surprising interaction of salan and alkoxy ligands.

Immel TA, Groth U, Huhn T.

Chemistry. 2010 Mar 1;16(9):2775-89. doi: 10.1002/chem.200902312.

PMID:
20104550
9.

Different ortho and para electronic effects on hydrolysis and cytotoxicity of diamino bis(phenolato) "salan" Ti(IV) complexes.

Peri D, Meker S, Manna CM, Tshuva EY.

Inorg Chem. 2011 Feb 7;50(3):1030-8. doi: 10.1021/ic101693v. Epub 2011 Jan 7.

PMID:
21214265
10.

Major impact of N-methylation on cytotoxicity and hydrolysis of salan Ti(IV) complexes: sterics and electronics are intertwined.

Meker S, Manna CM, Peri D, Tshuva EY.

Dalton Trans. 2011 Oct 14;40(38):9802-9. doi: 10.1039/c1dt11108f. Epub 2011 Aug 26.

PMID:
21874187
11.

Unexpected influence of stereochemistry on the cytotoxicity of highly efficient Ti(IV) salan complexes: new mechanistic insights.

Manna CM, Armony G, Tshuva EY.

Chemistry. 2011 Dec 9;17(50):14094-103. doi: 10.1002/chem.201102017. Epub 2011 Nov 10.

PMID:
22076809
12.

Trans titanium(IV) complexes of salen ligands exhibit high antitumor activity.

Tzubery A, Tshuva EY.

Inorg Chem. 2011 Sep 5;50(17):7946-8. doi: 10.1021/ic201296h. Epub 2011 Jul 28.

PMID:
21797239
14.

New insights on the active species and mechanism of cytotoxicity of salan-Ti(IV) complexes: a stereochemical study.

Manna CM, Armony G, Tshuva EY.

Inorg Chem. 2011 Oct 17;50(20):10284-91. doi: 10.1021/ic201340m. Epub 2011 Sep 16.

PMID:
21923127
15.

From catalysts to bioactive organometallics: do Grubbs catalysts trigger biological effects?

Oehninger L, Alborzinia H, Ludewig S, Baumann K, Wölfl S, Ott I.

ChemMedChem. 2011 Dec 9;6(12):2142-5. doi: 10.1002/cmdc.201100308. Epub 2011 Sep 7. No abstract available.

PMID:
21901835
16.

Anti-proliferative activity of nano-formulated phenolato titanium(IV) complexes against cancer cells.

Meker S, Margulis-Goshen K, Weiss E, Braitbard O, Hochman J, Magdassi S, Tshuva EY.

ChemMedChem. 2014 Jun;9(6):1294-8. doi: 10.1002/cmdc.201400038. Epub 2014 Mar 26.

PMID:
24677761
17.

Antitumor titanium compounds.

Caruso F, Rossi M.

Mini Rev Med Chem. 2004 Jan;4(1):49-60. Review.

PMID:
14754443
18.

Titanium complexes in cancer treatment.

Meléndez E.

Crit Rev Oncol Hematol. 2002 Jun;42(3):309-15. Review.

PMID:
12050022
19.

Active cytotoxic reagents based on non-metallocene non-diketonato well-defined C2-symmetrical titanium complexes of tetradentate bis(phenolato) ligands.

Shavit M, Peri D, Manna CM, Alexander JS, Tshuva EY.

J Am Chem Soc. 2007 Oct 10;129(40):12098-9. Epub 2007 Sep 18. No abstract available.

PMID:
17877357
20.

Supplemental Content

Support Center